AHR and necrotizing enterocolitis: Some investigators found the expression of AHR is significantly reduced in both in vitro studies and animal models.72,73 In particular, the use of AHR ligands indole-3-carbinol (I3C) or the clinical compound “A18” during pregnancy or of breast milk, effectively activates AHR of the intestine and prevents NEC in the offspring.